Lexibulin
Term · Oncology and biomedicine · MLC-T-ONC-014769
An orally bioavailable small-molecule with tubulin-inhibiting, vascular-disrupting, and potential antineoplastic activities. Lexibulin inhibits tubulin polymerization in tumor blood vessel endothelial cells and tumor cells, blocking the formation of the mitotic spindle and leading to cell cycle arrest at the G2/M phase; this may result in disruption of the tumor vasculature and tumor blood flow, and tumor cell death.
| Identifier | MLC-T-ONC-014769 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | vascular disrupting agent CYT997 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014769",
"term": "Lexibulin",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable small-molecule with tubulin-inhibiting, vascular-disrupting, and potential antineoplastic activities. Lexibulin inhibits tubulin polymerization in tumor blood vessel endothelial cells and tumor cells, blocking the formation of the mitotic spindle and leading to cell cycle arrest at the G2/M phase; this may result in disruption of the tumor vasculature and tumor blood flow, and tumor cell death.",
"synonyms": [
"vascular disrupting agent CYT997"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/lexibulin/"
}
Record 10,071 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.